Cargando…

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease

Parkinson's disease is a neurodegenerative disorder with uncertain aetiology and ill-defined pathophysiology. Activated microglial cells in the substantia nigra (SN) are found in all animal models of Parkinson's disease and patients with the illness. Microglia may, however, have detrimenta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godoy, María Clara Pott, Tarelli, Rodolfo, Ferrari, Carina Cintia, Sarchi, Maria Inés, Pitossi, Fernando Juan
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442423/ https://www.ncbi.nlm.nih.gov/pubmed/18504291 http://dx.doi.org/10.1093/brain/awn101

Ejemplares similares

Parkinson's Disease and Systemic Inflammation
por: Ferrari, Carina C., et al.
Publicado: (2011)

Neurodegeneration in the centrally-projecting Edinger–Westphal nucleus contributes to the non-motor symptoms of Parkinson’s disease in the rat
por: Ujvári, Balázs, et al.
Publicado: (2022)

Downregulation of Plasma Membrane Ca(2+) ATPase driven by tyrosine hydroxylase-Gal4 reduces Drosophila lifespan independently of effects in neurons
por: Erhardt, Brenda, et al.
Publicado: (2023)

The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
por: Harrison, Ian F., et al.
Publicado: (2018)

Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6
por: Murray, Carol L, et al.
Publicado: (2011)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Inflammation and Parkinson's Disease
por: Barcia, Carlos, et al.
Publicado: (2011)

Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease
por: Kostuk, Eric Wildon, et al.
Publicado: (2018)

Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration
por: Bieri, Gregor, et al.
Publicado: (2018)

Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
por: Blaylock, Russell L.
Publicado: (2017)

Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?
por: Leal, María C., et al.
Publicado: (2013)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration
por: Nunes-Costa, Daniela, et al.
Publicado: (2020)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
por: Wey, Margaret Chia-Ying, et al.
Publicado: (2012)

Increased fractional anisotropy in the motor tracts of Parkinson's disease suggests compensatory neuroplasticity or selective neurodegeneration
por: Mole, Jilu Princy, et al.
Publicado: (2016)

Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease
por: Tomic, Svetlana, et al.
Publicado: (2022)

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease
por: Kozina, Elena, et al.
Publicado: (2022)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
por: Zhang, Shi, et al.
Publicado: (2011)

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
por: Ramirez, Ana I., et al.
Publicado: (2017)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease
por: Santos-García, Diego, et al.
Publicado: (2023)

Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis
por: Kumari, Mangala, et al.
Publicado: (2021)

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease
por: Martinez, Paul Anthony, et al.
Publicado: (2023)

Editorial: Molecular Chaperones and Neurodegeneration
por: Roodveldt, Cintia, et al.
Publicado: (2017)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
por: Zeng, Xian-Si, et al.
Publicado: (2018)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
Publicado: (2020)

Association of p53 with Neurodegeneration in Parkinson's Disease
por: Luo, Qiang, et al.
Publicado: (2022)

APP-Induced Patterned Neurodegeneration Is Exacerbated by APOE4 in Caenorhabditis elegans
por: Sae-Lee, Wisath, et al.
Publicado: (2020)

Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling
por: Chang, Nydia P., et al.
Publicado: (2023)

Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Church, Frank C.
Publicado: (2021)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Drosophila Toll-9 is induced by aging and neurodegeneration to modulate stress signaling and its deficiency exacerbates tau-mediated neurodegeneration
por: Sakakibara, Yasufumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujls4c2hsjqkuemd7ji809m9av